<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[advisory committee and amgen inc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/advisory+committee+and+amgen+inc..html?i=11]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to advisory committee and amgen inc.]]></description>
	<s:counts start="0" returned="3" found="3" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_11/ai_n27369312]]></link>
		<description><![CDATA[Company Recommends Hemoglobin Target of 10-12 g/dL as Risk Management Approach]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 11 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/benefit.html"><![CDATA[benefit]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[FDA Advisory Committee Recommends Approval of Amgen's Kineret for the Treatment of Rheumatoid Arthritis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_August_16/ai_77268737]]></link>
		<description><![CDATA[Business Editors and Health Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 16 Aug 2001 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[FDA advisory committee unanimously recommends approval of Amgen's NEUPOGEN ® for peripheral blood progenitor cell support; recent data showed 30% cost savings over BMT]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1995_Nov_13/ai_17600284]]></link>
		<description><![CDATA[THOUSAND OAKS, Calif.--BUSINESS WIRE--Nov. 13, 1995--Amgen (NASDAQ:AMGN) Monday announced that the Biological Response Modifier's Advisory Committee BRMAC to the Food and Drug Administration voted unanimously (15-0) to recommend expanding the approved use of the company's recombinant human granulocyte colony-stimulating factor NEUPOGEN R (Filgrastim rG-CSF) to include use in peripheral blood...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 13 Nov 1995 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cost+savings.html"><![CDATA[cost savings]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
</channel>
</rss>
